Company
Valink Therapeutics
| Industry | biotechnology company developing next-generation oncology therapeutics with a focus on bispecific antibody-drug conjugates (bsADCs) and complementary modalities for improved patient outcomes |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Valink Therapeutics | Pre-A | 2025-10-20 |